PH12279A - Biguanide dichlorcacetates and pharmaceutical preparations containing them - Google Patents

Biguanide dichlorcacetates and pharmaceutical preparations containing them

Info

Publication number
PH12279A
PH12279A PH17640A PH17640A PH12279A PH 12279 A PH12279 A PH 12279A PH 17640 A PH17640 A PH 17640A PH 17640 A PH17640 A PH 17640A PH 12279 A PH12279 A PH 12279A
Authority
PH
Philippines
Prior art keywords
dichlorcacetates
biguanide
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Application number
PH17640A
Other languages
English (en)
Inventor
U Fischer
E Lorch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH12279A publication Critical patent/PH12279A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH17640A 1974-10-11 1975-10-08 Biguanide dichlorcacetates and pharmaceutical preparations containing them PH12279A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (de) 1974-10-11 1974-10-11

Publications (1)

Publication Number Publication Date
PH12279A true PH12279A (en) 1978-12-12

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17640A PH12279A (en) 1974-10-11 1975-10-08 Biguanide dichlorcacetates and pharmaceutical preparations containing them

Country Status (26)

Country Link
US (1) US4028402A (de)
JP (1) JPS51125718A (de)
AR (1) AR209457A1 (de)
AT (1) AT343676B (de)
BE (1) BE834369A (de)
BR (1) BR7506595A (de)
CA (1) CA1053258A (de)
CH (1) CH602612A5 (de)
CU (1) CU34371A (de)
DD (1) DD123322A5 (de)
DE (1) DE2542598A1 (de)
DK (1) DK140834B (de)
ES (1) ES441673A1 (de)
FI (1) FI752626A (de)
FR (1) FR2287221A1 (de)
GB (1) GB1473256A (de)
IE (1) IE41807B1 (de)
IL (1) IL48116A (de)
LU (1) LU73557A1 (de)
NL (1) NL7511890A (de)
NO (1) NO753447L (de)
PH (1) PH12279A (de)
PL (1) PL95259B1 (de)
SE (1) SE7511357L (de)
SU (1) SU572200A3 (de)
ZA (1) ZA755861B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
DE122010000020I1 (de) 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
EP1004304A4 (de) 1996-12-24 2002-10-16 Sumitomo Pharma Zusammensetzung mit acorbinsäure
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
CA2386379C (en) 1999-10-06 2009-12-15 Toshio Miyata Carbonyl stress-decreasing agent
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
IL151368A0 (en) * 2000-03-31 2003-04-10 Probiodrug Ag Use of a dipeptidyl peptidase iv enzyme activity effector for the production of pharmaceutical compositions
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
RU2003115614A (ru) * 2000-10-27 2004-10-27 Пробиодруг Аг (De) Способ лечения неврологических и нейропсихологических нарушений
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
JP2005504766A (ja) * 2001-08-16 2005-02-17 プロバイオドラッグ アーゲー プロリンエンドペプチダーゼ阻害剤の、細胞内シグナルカスケード依存性イノシトール（１，４，５）トリホスフェート濃度調節への使用。
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
ES2278944T3 (es) 2002-02-28 2007-08-16 Prosidion Ltd. Inhibidores de dpiv basados en glutaminilo.
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
AU2003293311A1 (en) * 2002-09-18 2004-04-23 Prosidion Ltd. Secondary binding site of dipeptidyl peptidase iv (dp iv)
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
KR20120035203A (ko) 2003-05-05 2012-04-13 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
EP2289498A1 (de) * 2003-10-15 2011-03-02 Probiodrug AG Verwendung von Inhibioten von Glutaminyl Cyclase
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
CN101652131A (zh) * 2007-01-29 2010-02-17 韩兀制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
WO2009038396A2 (en) * 2007-09-21 2009-03-26 Hanall Pharmaceutical Company. Ltd N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
WO2009088220A2 (ko) * 2008-01-08 2009-07-16 Hanall Pharmaceutical Company. Ltd Ｎ,ｎ-디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
CN102159539B (zh) 2008-06-26 2014-04-16 矽烷实验室股份公司 用于血糖控制的新型二甲双胍甘氨酸盐
US20110021634A1 (en) 2009-06-18 2011-01-27 Patel Pranav Dushyant Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
BR112019006401A2 (pt) 2016-09-30 2019-06-25 Laboratorios Silanes S A De C V glicinato de metformina, composições farmacêuticas que compreendem o mesmo e métodos de uso do mesmo
US11510886B2 (en) 2016-09-30 2022-11-29 Laboratorios Silanes, S.A. De C.V. Metformin amino acid compounds and methods of using the same
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
DK140834C (de) 1980-04-28
DK457475A (de) 1976-04-12
LU73557A1 (de) 1977-05-24
JPS51125718A (en) 1976-11-02
DE2542598A1 (de) 1976-04-22
FR2287221A1 (fr) 1976-05-07
IE41807B1 (en) 1980-03-26
BR7506595A (pt) 1976-08-17
CH602612A5 (de) 1978-07-31
SE7511357L (sv) 1976-04-12
IE41807L (en) 1976-04-11
AT343676B (de) 1978-06-12
NO753447L (de) 1976-04-13
ZA755861B (en) 1976-08-25
DK140834B (da) 1979-11-26
AR209457A1 (es) 1977-04-29
AU8497775A (en) 1977-03-24
IL48116A (en) 1979-07-25
PL95259B1 (pl) 1977-10-31
IL48116A0 (en) 1975-11-25
BE834369A (fr) 1976-04-12
US4028402A (en) 1977-06-07
ES441673A1 (es) 1977-04-01
ATA776375A (de) 1977-10-15
CA1053258A (en) 1979-04-24
GB1473256A (en) 1977-05-11
SU572200A3 (ru) 1977-09-05
DD123322A5 (de) 1976-12-12
CU34371A (es) 1979-06-01
FI752626A (de) 1976-04-12
NL7511890A (nl) 1976-04-13

Similar Documents

Publication Publication Date Title
PH12279A (en) Biguanide dichlorcacetates and pharmaceutical preparations containing them
IL47634A0 (en) Pharmaceutical skin permeating preparations
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
IL48637A0 (en) 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted omega-pentanorprostaglandins and pharmaceutical compositions containing them
NZ179496A (en) 1-substituted-4-( -substituted-benzylidene)-piperidenes and pharmaceutical compsitions
ZA751102B (en) Pharmaceutical preparations
IL46959A0 (en) 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them
ZA755929B (en) Aminobenzazocines and preparation thereof
IL47329A (en) Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IE42324L (en) Pharmaceutical preparations containing silicone rubber
IL46682A0 (en) Pharmaceutical preparations containing digoxin
JPS51142094A (en) Iodineecontained product and pharmaceutical composition containing thereof
AU4750079A (en) Pharmaceutical preparations
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
ZA755767B (en) Pharmaceutical preparations
IL48526A0 (en) Diaryloxy-imidazolyl-o,n-acetals,their preparation and pharmaceutical compositions containing them
ZA745114B (en) A medicament- thiazole 5-methanol and pharmaceutical compositions containing
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
IL46409A (en) 7,8-dihalo-1,2,3,4-tetrahydro-isoquinolines their preparation and pharmaceutical compositions containing them
IL48004A0 (en) Pesticidal tetrazoloquinazolines and compositions containing them
PH12224A (en) Sulfonyl urea derivatives and pharmaceutical preparations thereof
ZA747446B (en) Pharmaceutical preparations
IL48309A0 (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them
PH11824A (en) Benzo-naphthyridines and pharmaceutical compositions containing same
PH10795A (en) D-glucose-1-onicotinoyl-2-deoxy-2-nictinkmido derivatives and pharmaceutical composition thereof